IHL-305
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
On page 1208, Disclosure section, “The authors report no conflicts of interest in the work” has been updated since publication…
2547 Background: Irinotecan (CPT-11) is a prodrug of SN-38 that has antitumor activity in a wide range of solid tumors. IHL- 305…
To investigate pharmacokinetics (PK) of encapsulated CPT-11, released CPT-11 and the active metabolite SN-38 following…
The antitumor effect of IHL-305, a novel pegylated liposome containing irinotecan, was investigated in human…